Search clinical trials for: Infliximab at weeks 0,4, and 8

Total 311 results

NYU Langone Health

Withdrawn

Managing Infliximab Reinduction After Temporary Discontinuation of Drug

Inflammatory Bowel Disease
Oregon Health and Science University

Active, not recruiting

Virtual Yoga for Social Isolation and Loneliness in Rural Veterans

Loneliness | Social Isolation

United States
Aelix Therapeutics

Completed

Safety and Immunogenicity Study of DNA.HTI, MVA.HTI and ChAdOx1.HTI in HIV-1-positive Patients (AELIX-002)

HIV

Spain
State University of New York at Buffalo

Completed

Imagine to Remember: Improving Medication Adherence in Pre- and Type 2 Diabetes

Medication Adherence

United States
Centers for Disease Control and Prevention
International Centre for Diarrhoeal Disease Research, Bangladesh

Completed

Immunogenicity of Monovalent Type 2 Oral Poliovirus Vaccine

Poliomyelitis

Bangladesh
Merck Sharp & Dohme LLC

Terminated

Treatment With Infliximab in a Medical Setting (Study P05587) (OPTIMIST)

Crohn's Disease
Sixth Affiliated Hospital, Sun Yat-sen University

Unknown

The Therapy Effect of Azathioprine Initial or 14 Weeks After Combined With Infliximab on CD

Crohn Disease

China
IrsiCaixa
José Moltó Marhuenda, PhD, MD; Beatriz Mothe Pujadas PhD,MD; Susana Benet Garrabé... and other collaborators

Completed

A Phase I, Randomized, Double-Blind, Placebo-Controlled Safety, Tolerability and Immunogenicity Study of Candidate HIV-1 Vaccines ChAdOx1.HTI and MVA.HTI With Recombinant HIV-1 Envelope Protein ConM SOSIP.v7 gp140 Vaccine, Adjuvanted With MPLA Liposomes in ART-Suppressed HIV-1 Positive Individuals

HIV Infection

Spain
University Hospital Inselspital, Berne

Completed

The Radiation Metabolic Signature of Patient Undergoing Radiotherapy. A Pilot Study

Breast Cancer

Switzerland
Centers for Disease Control and Prevention
International Centre for Diarrhoeal Disease Research, Bangladesh

Completed

Fractional Inactivated Poliovirus Vaccine Booster and Rotavirus Study (fIPV)

Poliomyelitis

Bangladesh
Spanish Clinical Pharmacology Society
Spanish reumatology Society

Completed

Evaluation of a Protocol for Dose Reduction in Patients With Spondylarthropathies and Clinical Remission With Anti-TNF (REDES-TNF)

Spondylarthropathies

Spain
National Taiwan University Hospital
National Science Council, Taiwan

Unknown

Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Negative Chronic Hepatitis B

Hepatitis B, Chronic

Taiwan
University of Iowa

Completed

Efficacy of Brief Acceptance and Commitment Therapy (ACT) for Perinatal Anxiety

Post Partum Depression | Perinatal Depression | Perinatal Anxiety | Post Partum Anxiety

United States
Qatar University
Hamad Medical Corporation

Completed

Assessing the Effectiveness of a Pharmacist-delivered Smoking Cessation Program in the State of Qatar

Smoking Cessation

Qatar
Rheumazentrum Ruhrgebiet
PPD; Centocor BV; Trial Coordination Center, 9713 GZ Groningen

Unknown

Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis

Ankylosing Spondylitis

Belgium, Germany, Finland, France, Netherlands, United Kingdom
University Health Network, Toronto

Active, not recruiting

Biologic Tapering Study of TNF Inhibitors in Axial Spondyloarthritis (BIOTAPE)

Axial Spondyloarthritis

Canada
University Hospital, Rouen

Not yet recruiting

Efficacy of Glutamine Supplementation in Patients Suffering From Irritable Bowel Syndrome With Impaired Intestinal Permeability (MISSISIIPI)

Irritable Bowel Syndrome
Heartfulness Institute
Angell Animal Medical Center

Completed

Effect of an 8-week Heartfulness Meditation Program on Burnout and Stress at Veterinary Specialty Hospital

Stress | Burnout, Professional

United States
Centers for Disease Control and Prevention
International Centre for Diarrhoeal Disease Research, Bangladesh

Completed

Duration of IPV Priming and Antibody Decay

Poliomyelitis

Bangladesh
Istituto Scientifico Romagnolo per lo Studio e...

Unknown

Optimizing the Interval Between Cycles of PRRT With 177lu-dotatate in sstr2 Positive Tumors (LUTHREE)

Neuroendocrine Tumors

Italy
Centocor, Inc.

Completed

A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Moderate to Severe Active Crohn's Disease

Crohn Disease
Centocor, Inc.

Completed

A Study of the Safety and Efficacy of Infliximab (Remicade) in Subjects With Fistulizing Crohn's Disease

Crohn Disease
Laval University

Active, not recruiting

Effects of Blueberry on Gut Microbiota and Metabolic Syndrome

Metabolic Syndrome | Gut Microbiota

Canada
Fuji Yakuhin Co., Ltd.

Completed

Study of FYU-981 in Hyperuricemia With or Without Gout

Hyperuricemia

Japan
University of Ulster
Western Health and Social Care Trust

Suspended

Replenishing and Maintaining Vitamin D Status in Older Adults in Residential Care Facilities in NI

Vitamin D Deficiency

United Kingdom
Hospital de Clinicas de Porto Alegre

Unknown

Iron Supplementation in Heart Failure Patients With Anemia: The IRON-HF Study

Heart Failure | Anemia

Brazil
Janssen Research & Development, LLC
Janssen Biologics BV

Completed

A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients

Ulcerative Colitis

United States, France, United Kingdom, Belgium, Switzerland, Israel, Canada, Australia, Netherlands, New Zealand, Austria, Germany, Denmark, Czechia, Argentina
Rigshospitalet, Denmark
Nordic Society for Pediatric Hematology and Oncology

Completed

ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia Intermittent Versus Continuous PEG Asparaginase

Acute Lymphoblastic Leukemia

Finland, Denmark, Norway, Sweden, Iceland
The University of Texas Health Science Center,...
Harris Health System, Lyndon B Johnson Hospital obstetrics and gynecology...

Withdrawn

Early Term Delivery Versus Expectant Management of the Large for Gestational Age Fetus (TEAM LGA)

Labor Induction | Macrosomia, Fetal
Merck Sharp & Dohme LLC

Terminated

Long-Term Effects of Infliximab in the Treatment of Moderate to Severe Psoriasis [Extension of Study P04271, NCT00251641] (P04563)

Psoriasis
Hospital General de Mexico
Schering-Plough

Completed

Efficacy, Safety, and Tolerability Study of Infliximab in Juvenile Spondyloarthropathies

Spondylarthropathies

Mexico
University of Beira Interior
Research Center in Sports Sciences, Health Sciences and Human Development...

Recruiting

Resistance Training for Individuals With Mild Cognitive Impairment (TRAIN4BRAIN)

Mild Cognitive Impairment | Mild Dementia

Portugal
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety and Effectiveness of Ertapenem Versus Ceftriaxone/Metronidazole in the Treatment of Intra-abdominal Infections in Adults (0826-802)

Intra-abdominal Infection
The Hong Kong Polytechnic University

Completed

The Effects of the Hopeful Outdoor Parkinson Exercise (HOPE) Program on Improving Balance Performance in Parkinsonian Non-fallers and Single Fallers

Parkinson's Disease

China
The Alfred
Merck Sharp & Dohme LLC

Unknown

Comparison of the Performance of SB2-Infliximab With Originator Infliximab in the Measure of Serum Concentrations in Serum

Inflammatory Bowel Diseases
Merck Sharp & Dohme LLC
Centocor, Inc.

Completed

European Safety Registry in Ulcerative Colitis (P04808) (OPUS)

Ulcerative Colitis
QuatRx Pharmaceuticals Company
Hormos Medical

Completed

Efficacy and Safety Evaluating Fispemifene in the Treatment of Hypogonadal Men With Erectile Dysfunction Unresponsive to PDE5 Inhibitors

Erectile Dysfunction | Hypogonadism

United States
Assistance Publique - Hôpitaux de Paris

Completed

Development of a Visio-behavioral Scale to Evaluate Visual Abilities of Patients With Profound Multiple Intellectual Disabilities (PLH-Vision) (PLH-Vision)

Profound Multiple Intellectual Disabilities

France
University of Athens

Terminated

Treatment of Refractory Diabetic Macular Edema With Infliximab

Diabetic Retinopathy | Diabetic Macular Edema | Visual Acuity

Greece
University of Maryland, Baltimore

Completed

Intraoral Imaging at Clinical Crown Lengthening

Surgery | Dental Caries of Root Surface

United States
Hikma Pharmaceuticals LLC
Syneos Health

Completed

Safety Study of Remsima® (Infliximab) in Rheumatoid Arthritis Patients in Jordan (PASSRRA)

Rheumatoid Arthritis

Jordan
ASIS Corporation

Unknown

ASIS for Enbrel in Plaque Psoriasis (ASISinPP)

Plaque Psoriasis.

United States
Fundacion Clinic per a la Recerca Biomédica

Unknown

Efficacy of GZR/EBR in Early Chronic Hepatitis C in HIV/HCV Co-infected Patients (EARLY-HEP-C)

Hepatitis C | HIV

Spain
University Hospital, Grenoble

Completed

Matrix Metalloproteinase-1/Tissue Inhibitor of Metalloproteinase-1 (MMP-1/TIMP-1) Ratio and Diabetic Foot Ulcers (DIAB-MMP2)

Diabetic Foot Ulcer

France
Central Jutland Regional Hospital
Aarhus University Hospital; University of Aarhus; VIA University College

Withdrawn

Supervised Exercise Following Pulmonary Embolism

Pulmonary Embolism
ASIS Corporation

Unknown

ASIS for GAMMAGARD in Primary Immunodeficiency (ASISinPI)

Primary Immunodeficiency

United States
CytoDyn, Inc.
Amarex Clinical Research

Withdrawn

Leronlimab in Combination With Regorafenib in Patients With CCR5+, Metastatic Colorectal Cancer

Colorectal Cancer | Microsatellite Stable | Metastatic | CCR5
University of Texas, El Paso

Completed

Type 2 Diabetes Affect Exercise Induced Improvement in Insulin Sensitivity (HIT)

Insulin Sensitivity/Resistance

United States
Hospital General Universitario Gregorio Marañon
Karolinska Institutet; Universidad Europea de Madrid

Completed

Strength Training in Nonagenarians (STRONG)

Elderly

Spain
Taizhou Mabtech Pharmaceutical Co.,Ltd

Completed

The Study of Infliximab (CMAB008 and Remicade) in Healthy Subjects to Compare the PK and Safety

Rheumatoid Arthritis

China

Search clinical trials for: Infliximab at weeks 0,4, and 8

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations